WELL Health Technologies Corp. (TSX: WELL)

As AI evolves in healthcare, the challenge of safeguarding patient data and privacy grows. See how WELL AI Voice, a WELL Health AI solution, meets these challenges and ensures your practice stays compliant. Discover how WELL AI Voice adheres to regulatory standards and best practices: https://ow.ly/WRO850Utxal

WELL's subsidiaries, OSCAR Pro and DoctorCare recently came together for the OSCAR Pro User Day event in Toronto! 🎉 It was a great opportunity to connect with users, share insights, and explore how we can better support the healthcare community. From hands-on feature demos and sessions on optimizing clinical workflows with OSCAR Pro to learning medical billing strategies from DoctorCare, it was inspiring to see everyone's commitment to transforming healthcare. A big thank you to our team for an unforgettable day of insights & collaboration and everyone who joined us and made the day a success! 📸

Following WELL's announcement of rebranding its subsidiary, WELL Provider Solutions Group, into WELLSTAR, along with recent acquisitions, Beacon Securities Limited analyst Gabriel Leung has raised his price target for WELL to $9.00. Leung emphasizes the positive impact of the WELLSTAR spin-off, noting it will reduce capital costs and drive strong revenue growth in 2025. Read Leung’s outlook in Cantech Letter's recent article: https://ow.ly/oIzp50UqW2u

WELL is pleased to announce the creation of WELLSTAR Technologies Corp., a reorganization of WELL’s established WELL Provider Solutions Group. WELLSTAR aims to be the leading provider of healthcare technology solutions in Canada. WELLSTAR is a high-growth, profitable SaaS healthcare technology company supporting over 37,000 healthcare providers across Canada with technology and services that enhance patient care. To support its growth, WELLSTAR secured $50.4M in equity funding from Mawer Investment Management, EdgePoint Wealth Management, PenderFund Capital Management, along with participation from WELL and WELLSTAR management, to fund its pre-spinout growth objectives. WELLSTAR also acquired two healthcare technology companies, projecting 2025 proforma revenue to exceed $70M with 20% EBITDA margins. This investment values WELLSTAR at a pre-financing enterprise value of approximately $285M. WELLSTAR’s management team, which includes Amir Javidan, WELL’s COO and CEO of WELLSTAR, and Darren Hoegler as CFO, will be supported by the WELLSTAR board of directors, which includes Hamed Shahbazi, Chairman and CEO of WELL, who will also act as Chairman, alongside Amir Javidan, and Ammar Shah, CFA, Vice President of Corporate Development and Strategy at WELL. Two additional independent board members will be appointed soon, one by WELL and one by Mawer. https://ow.ly/F29q50UpQ0F

With innovative solutions from WELL Health AI like WELL AI Voice, WELL is pushing the boundaries of what’s possible in healthcare, empowering providers to improve both efficiency and patient care, focusing more of their valuable time on patient care and less on administration. François-Philippe Champagne, Minister of Innovation, Science and Industry of Canada, experienced a firsthand demonstration of WELL AI Voice, witnessing its potential to transform clinical workflows efficiently and precisely. This cutting-edge tool is designed to help healthcare professionals streamline their workflows by: ➡️ Seamlessly creating SOAP notes ➡️ Automatically generating encounter notes from doctor-patient conversations directly into the EMR ➡️ Reducing time spent on manual note-taking and administration ➡️ Offering personalized recommendations and treatment options based on the latest medical guidelines and research In a recent video, Amir Javidan, COO of WELL, and Shane Sabatino, Public Sector Partnership Leads of WELL, discuss the transformative impact of WELL AI Voice on healthcare providers and patients alike. 📹 https://ow.ly/wQyB50UpbVI

How is healthcare shifting from reactive treatment to proactive prevention? Dr. Grant Meek dives into WELL's Longevity Program—a predictive health model identifying potential risks before symptoms or disease appear. Through total body scans, molecular biomarker testing, and personalized care, the program helps people take control of their health journey—empowering them to live longer, not just better. Read Dr. Meek's breakdown of WELL's Longevity Program here: https://ow.ly/ipvh50Uojmm

TD analyst David Kwan maintains his "Buy" rating and $8.00 price target on WELL, highlighting continued growth potential with key catalysts ahead. Curious about what’s driving his optimism? Read Cantech Letters' recent report for the full analysis. https://ow.ly/777u50UnT13

Some behind-the-scenes fun with WELL's BC Clinic Managers at their 4th annual holiday lunch! 🎉 A fun tradition that highlights our clinic managers' spirit and showcases the strong teamwork, impact, and leadership they bring to our health providers and the communities we serve.

What a great time we had at the Providence Health Care St. Paul's Hospital Continuing Medical Education Conference for Primary Care Physicians at the Vancouver Convention Centre! Joined by teams from OSCAR Pro, WELL Health AI, OceanMD, a WELL Health Company and WELL Health Clinics, we enjoyed discussing how WELL’s solutions and services streamline workflows, enhance clinical decision-making, and improve healthcare efficiency and patient outcomes. In line with our dedication to clinician wellness and education, WELL was proud to be a conference supporter of the Find Meaning and Joy in Family Medicine session. We appreciate everyone who took the time to visit us, and a special thanks to the organizers and attendees for making the event truly memorable! 💙

WELL has completed the acquisition of the Canadian clinical assets of Jack Nathan Medical Corp. The transaction includes 13 owned and operated primary care clinics across 10 Canadian cities, generating over $9 million in revenue over the past 12 months, as well as 59 licensee clinics now operating under WELL's new Affiliate Clinic business model, contributing $2.2 million annually in high-margin revenue. The acquired clinics will be rebranded as WELL Health Medical Centres, reflecting WELL's tech-enabled approach to delivering quality healthcare. Additionally, WELL has entered into various agreements with Walmart Canada that provide a framework to support the potential expansion of WELL's clinical network within Walmart Canada's footprint of over 400 locations over time. Hamed Shahbazi, Founder and CEO of WELL, commented, "Through the newly acquired licensing arrangement with Walmart Canada, WELL gains a unique opportunity to deliver care conveniently in high-traffic, densely populated areas within Walmart Canada's footprint of over 400 locations, including geographies not currently served by WELL." Read WELL's full PR: https://ow.ly/snUK50Uj40F